Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis.

[1]  B. Modan,et al.  Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. , 1990, Journal of the National Cancer Institute.

[2]  Guowang Xu,et al.  Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  A. Branchi,et al.  Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects , 2000, International journal of clinical & laboratory research.

[4]  Anna N. Vioral,et al.  Breast Cancer Overview , 2007, Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses.

[5]  Y. Li,et al.  Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  W. R. Wikoff,et al.  Metabolomics identifies perturbations in human disorders of propionate metabolism. , 2007, Clinical chemistry.

[7]  W. Matson,et al.  Metabolomic profiling to develop blood biomarkers for Parkinson's disease. , 2008, Brain : a journal of neurology.

[8]  D. De Bacquer,et al.  Consumption of fatty acids in Belgium and its relationship with cancer mortality. , 1997, Cancer letters.

[9]  X. Zhang,et al.  Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  K. Punnonen,et al.  Phospholipids and fatty acids in breast cancer tissue , 2004, Journal of Cancer Research and Clinical Oncology.

[11]  L. Dogliotti,et al.  Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. , 1994, European journal of cancer.

[12]  J. Lampe,et al.  Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. , 2007, The American journal of clinical nutrition.

[13]  X. Shu,et al.  Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: A prospective cohort study , 2011, International journal of cancer.

[14]  Younghoon Kim,et al.  Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification , 2009, Bioinform..

[15]  H. Patel,et al.  Significance of Alterations in Plasma Lipid Profile Levels in Breast Cancer , 2008, Integrative cancer therapies.

[16]  R. Molina,et al.  Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. , 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[17]  Johan Lindberg,et al.  Statistical multivariate metabolite profiling for aiding biomarker pattern detection and mechanistic interpretations in GC/MS based metabolomics , 2007, Metabolomics.

[18]  Donald L Weaver,et al.  Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Mariusz Kowalczyk,et al.  A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS. , 2004, Analytical chemistry.

[20]  D. Rose,et al.  Omega-3 fatty acids as cancer chemopreventive agents. , 1999, Pharmacology & therapeutics.

[21]  U. Peters,et al.  Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers , 2009, Cancer Causes & Control.

[22]  Johan Trygg,et al.  High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. , 2005, Analytical chemistry.

[23]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[24]  T. Bathen,et al.  MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status , 2007, Breast Cancer Research and Treatment.

[25]  B. El-Gamal,et al.  Serum lipids and tissue DNA content in Egyptian female breast cancer patients. , 2003, Japanese journal of clinical oncology.

[26]  Younghoon Kim,et al.  Multivariate classification of urine metabolome profiles for breast cancer diagnosis , 2009, BMC Bioinformatics.

[27]  Robert Tibshirani,et al.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition , 2001, Springer Series in Statistics.

[28]  L. Vatten,et al.  Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: a case-control study from the Janus serum bank in Norway. , 1993, European journal of cancer.

[29]  P. Greenwald.  Role of dietary fat in the causation of breast cancer: point. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  S. Kachhap,et al.  Effect of ω-6 polyunsaturated fatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line , 2000 .

[31]  Andreas Makris,et al.  Early breast cancer , 2009, The Lancet.

[32]  I. Bertini,et al.  Metabolomics: available results, current research projects in breast cancer, and future applications. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  B. Shatenstein,et al.  A case-control study of breast cancer and dietary intake of individual fatty acids and antioxidants in Montreal, Canada. , 2003, Breast.

[34]  Martín Velasco,et al.  Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients , 2004, Breast Cancer Research and Treatment.

[35]  P. Ferrari,et al.  The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy , 1999, British Journal of Cancer.

[36]  M. Barker,et al.  Partial least squares for discrimination , 2003 .

[37]  M. Patti,et al.  Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling. , 2008, Journal of biochemistry.

[38]  Tao-Tao Liu,et al.  A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.